QuidelOrtho
QDEL
#3554
Rank
$2.77 B
Marketcap
$41.45
Share price
-1.71%
Change (1 day)
-55.03%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

Operating Margin for QuidelOrtho (QDEL)

Operating Margin as of April 2024 (TTM): 2.15%

According to QuidelOrtho's latest financial reports and stock price the company's current Operating Margin is 2.15%. At the end of 2022 the company had an Operating Margin of 22.53%.

Operating Margin history for QuidelOrtho from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202222.53%-57.49%
202153.01%-15.33%
202062.61%333.9%
201914.43%18.89%
201812.14%-519.45%
2017-2.89%-65.78%
2016-8.45%78.35%
2015-4.74%-21.18%
2014-6.01%-407.21%
20131.96%-59.94%
20124.89%-32.51%
20117.24%-147.11%
2010-15.37%-148.42%
200931.74%36.63%
200823.23%33.65%
200717.38%22.62%
200614.18%-345.64%
2005-5.77%-386.72%
20042.01%-81.77%
200311.04%196.38%
20023.72%-28.45%
20015.21%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
14.17% 559.07%๐Ÿ‡บ๐Ÿ‡ธ USA
9.46% 340.00%๐Ÿ‡บ๐Ÿ‡ธ USA
26.34% 1,125.12%๐Ÿ‡บ๐Ÿ‡ธ USA
14.13% 557.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-4.25%-297.67%๐Ÿ‡บ๐Ÿ‡ธ USA
16.31% 658.60%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.